PBAC chair Professor Andrew Wilson was the first to call for a review. He argued for the review in response to concerns over a 'piecemeal' approach to policy. A 'piecemeal' approach to the review hardly seems an appropriate response.

Latest Video
New Stories
-
Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - - Latest News -
Orthocell boosts balance sheet with capital raise to drive nerve repair product growth
October 19, 2025 - - Australian Biotech -
Amplia targets US market expansion as FAK inhibitor shows promise in pancreatic cancer
October 19, 2025 - - Australian Biotech -
New combination therapy sets landmark survival benchmark in bladder cancer treatment
October 19, 2025 - - Latest News -
AdvanCell unveils promising first clinical results for 212Pb-ADVC001 in prostate cancer
October 19, 2025 - - Australian Biotech -
Trump announces third MFN deal with a focus on fertility drug costs and expanding IVF access
October 18, 2025 - - Latest News -
An exceptional outcome that must not become an exception
October 18, 2025 - - Latest News